<DOC>
	<DOCNO>NCT00421265</DOCNO>
	<brief_summary>In patient prostate cancer indolent feature , disease progrssion may slow many case never become clinically evident patient 's lifetime . Active surveillance continuous process monitoring disease characteristcs aim avoid morbidity active therapy patient stabe indolent parameter , offer early detection disease activity others need active therapy control disease . We hypothesize active surveillance permit avoidance therapy relate morbidity majority appropriate patient associate maintain quality life .</brief_summary>
	<brief_title>Active Surveillance Prostate Cancer With Indolent Features</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Men 65 year age old diagnosed prostate cancer past 3 month prior inclusion 2 . Gleason 's score 6 less . 3 . Clinical T1C per digital rectal exam . 4 . Pre biopsy PSA serum level 6.0ng/ml le . 5 . The presence cancer single biopsy core least 8 take . 6 . The presence cancer 10 % length core involve . 7 . Patient 's consent engage active surveillance inform benefit potential risk approach well alternative line therapy . 8 . Israeli residence readiness available followup schedule . Patients meet eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>active surveillance</keyword>
	<keyword>indolent feature</keyword>
</DOC>